Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer

The present study was conducted to evaluate the efficacy and safety of a combination regimen of capecitabine plus irinotecan in patients with advanced gastric cancer. Patients with previously untreated metastatic or recurrent, measurable gastric cancer received oral capecitabine 1000 mg m(−2) twice...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Baek, J H, Kim, J G, Jeon, S B, Chae, Y S, Kim, D H, Sohn, S K, Lee, K B, Choi, Y J, Shin, H J, Chung, J S, Cho, G J, Jung, H Y, Yu, W
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2006
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361294/
https://ncbi.nlm.nih.gov/pubmed/16641916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603093
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki